Diabetes Is Associated with Increased Autoreactivity of Mannan-Binding Lectin

Journal of Diabetes Research

Volumn 2017, Issue , 2017, Pages

  Axelgaard, Esben ^a   Østergaard, Jakob Appel ^b,c   Thiel, Steffen ^a   Hansen, Troels Krarup ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Danish Diabetes Academy   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; EPITOPE; GLUCOSE; MANNAN BINDING LECTIN; RECOMBINANT PROTEIN; GLUCOSE BLOOD LEVEL; MANNOSE BINDING LECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; COMPLEMENT ACTIVATION; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EX VIVO STUDY; FLUORESCENCE IMAGING; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WILD TYPE MOUSE; ALBUMINURIA; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; KIDNEY; METABOLISM; PATHOLOGY; URINE;

ALBUMINURIA; ANIMALS; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; KIDNEY; MANNOSE-BINDING LECTIN; MICE; MICE, KNOCKOUT;

EID: 85015703534     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2017/6368780     Document Type: Article

References (31)

1. EuropeanRenal AssociationAnd EuropeanDialysis andTransplant Association, ERA-EDTA Registry-Annual Report 2013.
2. USRDS, 2014 USRDS Annual Data Report Volume 2: End-Stage Renal Disease, vol. 2, 2014.
3. P. Hovind, L. Tarnow, K. Rossing, et al., "Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes, " Diabetes Care, vol. 26, no. 4, pp. 1258-1264, 2003.
4. H. Yokoyama, M. Okudaira, T. Otani, et al., "Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in earlyonset diabetes in Japan, " Kidney International, vol. 58, no. 1, pp. 302-311, 2000.
5. T. K. Hansen, S. Thiel, S. T. Knudsen, et al., "Elevated levels of mannan-binding lectin in patients with type 1 diabetes, " Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 10, pp. 4857-4861, 2003.
6. J. Østergaard, T. K. Hansen, S. Thiel, and A. Flyvbjerg, "Complement activation and diabetic vascular complications, " Clinica Chimica Acta, vol. 361, no. 1-2, pp. 10-19, 2005.
7. T. K. Hansen, L. Tarnow, S. Thiel, et al., "Association between mannose-binding lectin and vascular complications in type 1 diabetes, " Diabetes, vol. 53, no. 6, pp. 1570-1576, 2004.
8. J. Østergaard, S. Thiel, M. Gadjeva, T. K. Hansen, R. Rasch, and A. Flyvbjerg, "Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice, " Diabetologia, vol. 50, no. 7, pp. 1541-1549, 2007.
9. J. Acosta, J. Hettinga, R. Flückiger, et al., "Molecular basis for a link between complement and the vascular complications of diabetes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 10, pp. 5450-5455, 2000.
10. J. A. Østergaard, M. Bjerre, S. P. Ramachandrarao, et al., "Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model, " Experimental Diabetes Research, vol. 2012, Article ID 678381, 9 pages, 2012.
11. J. A. østergaard, M. Bjerre, F. Dagnæs-Hansen, T. K. Hansen, S. Thiel, and A. Flyvbjerg, "Diabetes-induced changes inmannanbinding lectin levels and complement activation in a mouse model of type 1 diabetes, " Scandinavian Journal of Immunology, vol. 77, no. 3, pp. 187-194, 2013.
12. J. A. Østergaard, M. M. Ruseva, T. H. Malik, et al., "Increased autoreactivity of the complement-Activating molecule mannanbinding lectin in a type 1 diabetes model, " Journal of Diabetes Research, vol. 2016, Article ID 1825738, 7 pages, 2016.
13. D. Ricklin, and J. D. Lambris, "Complement in immune and inflammatory disorders: pathophysiological mechanisms, " Journal of Immunology, vol. 190, no. 8, pp. 3831-3838, 2013.
14. S. Thiel, "Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins, " Molecular Immunology, vol. 44, no. 16, pp. 3875-3888, 2007.
15. S. E. Degn, and S. Thiel, "Humoral pattern recognition and the complement system, " Scandinavian Journal of Immunology, vol. 78, no. 2, pp. 181-193, 2013.
16. S. E. Degn, T. R. Kjaer, R. T. Kidmose, et al., "Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 37, pp. 13445-13450, 2014.
17. M. Endo, H. Ohi, I. Ohsawa, T. Fujita, M. Matsushita, and T. Fujita, "Complement activation through the lectin pathway in patients with Henoch-Schonlein purpura nephritis, " American Journal of Kidney Diseases, vol. 35, no. 3, pp. 401-407, 2000.
18. M. Møller-Kristensen, W. Wang, M. Ruseva, et al., "Mannanbinding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury, " Scandinavian Journal of Immunology, vol. 61, no. 5, pp. 426-434, 2005.
19. M. Endo, H. Ohi, I. Ohsawa, T. Fujita, M. Matsushita, and T. Fujita, "Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy, " Nephrology Dialysis Transplantation, vol. 13, no. 8, pp. 1984-1990, 1998.
20. D. Aronson, "Hyperglycemia and the pathobiology of diabetic complications, " Advances in Cardiology, vol. 45, pp. 1-16, 2008.
21. M. Ruseva, M. Kolev, F. Dagnaes-Hansen, et al., "Mannanbinding lectin deficiency modulates the humoral immune response dependent on the genetic environment, " Immunology, vol. 127, no. 2, pp. 279-288, 2009.
22. G. H. Tesch, and T. J. Allen, "Rodent models of streptozotocininduced diabetic nephropathy (methods in renal research), " Nephrology, vol. 12, no. 3, pp. 261-266, 2007.
23. G. W. Hung, "Stereological methods. Vol. 1: practical methods for biological morphometry: by Ewald R. Weibel, New York/London, " Microchemical Journal, vol. 29, no. 3, pp. 397-399, 1984.
24. S. V. Petersen, S. Thiel, L. Jensen, R. Steffensen, and J. C. Jensenius, "An assay for the mannan-binding lectin pathway of complement activation, " Journal of ImmunologicalMethods, vol. 257, no. 1-2, pp. 107-116, 2001.
25. M.V.Nesterenko, M. Tilley, and S. J. Upton, "Asimple modification of Blum?s silver stainmethod allows for 30 minite detection of proteins in polyacrylamide gels, " Journal of Biochemical and Biophysical Methods, vol. 28, no. 3, pp. 239-242, 1994.
26. P. Hovind, T. K. Hansen, L. Tarnow, et al., "Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study, " Diabetes, vol. 54, no. 5, pp. 1523-1527, 2005.
27. M. Saraheimo, C. Forsblom, T. K. Hansen, et al., "Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy, " Diabetologia, vol. 48, no. 1, pp. 198-202, 2005.
28. L. H. Bouwman, P. Eerligh, O. T. Terpstra, et al., "Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles, " Diabetes, vol. 54, no. 10, pp. 3002-3006, 2005.
29. J. A. Østergaard, S. Thiel, M. Lajer, et al., "Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: A 12-Year Follow-up Study, " Diabetes Care, vol. 38, no. 10, pp. 1898-1903, 2015.
30. P. Matzinger, "Tolerance, danger, and the extended family, " Annual Review of Immunology, vol. 12, pp. 991-1045, 1994.
31. E. H. Karunanayake, J. R. J. Baker, R. A. Christian, D. J. Hearse, and G. Mellows, "Autoradiographic study of the distribution and cellular uptake of (14C)-streptozotocin in the rat, " Diabetologia, vol. 12, no. 2, pp. 123-128, 1976.